CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D02-02-2022
02-02-2022
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q3 FY22 post results conference call details29-01-2022
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Notice of loss of share certificate of the Company26-01-2022
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of notice of 2nd Extra Ordinary General Meeting of the financial year 2021-2022 of Cadila Healthcare Limited published in the Financial Express English and Gujarati Editions, both on January 26, 202226-01-2022
CADILA HEALTHCARE LTD. - 532321 - Notice Of 2Nd Extra Ordinary General Meeting Of The Financial Year 2021-2022 Of The Members Of The Company
Notice of 2nd Extra Ordinary General Meeting of the financial year 2021-2022 of the members of the Company25-01-2022
CADILA HEALTHCARE LTD. - 532321 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter / Nine Months Ended On December 31, 2021
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 ,inter alia, to consider and approve Approval of the unaudited financial results for the quarter / nine months ended on December 31, 202125-01-2022
Cadila re-appoints Sharvil P Patel as MD for another five-year term
The company's board based on the recommendation of the nomination and remuneration committee and subject to approval of the members of the company has approved the proposal to re-appoint Patel as the MD for a further period of five years till March 31, 2027, the drug firm said in a regulatory filing.21-01-2022
CADILA HEALTHCARE LTD. - 532321 - Board Meeting Outcome for Re-Appointment Of Dr. Sharvil P. Patel As The Managing Director
Re-appointment of Dr. Sharvil P. Patel as the Managing Director subject to approval of shareholders.21-01-2022
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from USFDA for Vigabatrin Tablets20-01-2022
CADILA HEALTHCARE LTD. - 532321 - Compliance With SEBI Circular Dated November 3, 2021
Notice to shareholders of the Company holding shares in physical form with regard to norms for furnishing PAN, KYC details and Nomination18-01-2022